Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2022 | Centauri Therapeutics | $33.0M Series A | — | Boehringer Ingelheim Venture Fund, Johannes Zanzinger, Karen Lackey, Kent Life Science, Camilla Petrycer Hansen, Wren Capital |
| Jan 18, 2016 | Centauri Therapeutics | $4.3M Seed | — | — |